PAM
PVLA

Panagora Asset Management’s Palvella Therapeutics PVLA Stock Holding History

Panagora Asset Management’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-207
Closed -$42K – 2981
2021
Q1 		$42K Sell
207
-10
-5% -$2.19K ﹤0.01% 2211
2020
Q4 		$43K Hold
217
– – ﹤0.01% 2076
2020
Q3 		$36K Sell
217
-649
-75% -$148K ﹤0.01% 2095
2020
Q2 		$215K Buy
866
+120
+16% +$28.1K ﹤0.01% 1502
2020
Q1 		$136K Sell
746
-852
-53% -$215K ﹤0.01% 1586
2019
Q4 		$463K Buy
+1,598
New +$443K ﹤0.01% 1317
2017
Q4 		– Sell
-464
Closed -$214K – 2365
2017
Q3 		$214K Hold
464
– – ﹤0.01% 1654
2017
Q2 		$188K Buy
464
+213
+85% +$62.2K ﹤0.01% 1683
2017
Q1 		$52K Hold
251
– – ﹤0.01% 2012
2016
Q4 		$28K Hold
251
– – ﹤0.01% 2170
2016
Q3 		$37K Buy
+251
New +$33.4K ﹤0.01% 2178

Other funds holding PVLA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Panagora Asset Management's PVLA Position: Q2 2021 in Review

Panagora Asset Management sold out of Palvella Therapeutics (PVLA) in Q2 2021, closing a stake of 207 shares — an estimated $42K sold.

Panagora Asset Management first reported a position in PVLA in Q3 2016 and held it in 11 quarters. The position peaked at $463K in Q4 2019. 73 funds tracked by Wall St. Rank hold PVLA as of Q2 2021.

  • Panagora Asset Management reported no remaining Palvella Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Panagora Asset Management sold 207 Palvella Therapeutics shares in Q2 2021, an estimated $42K.
  • Panagora Asset Management first reported a position in Palvella Therapeutics in Q3 2016 and held it in 11 quarters.
  • Panagora Asset Management's Palvella Therapeutics position peaked at $463K in Q4 2019.
  • 73 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2021.

Based on Panagora Asset Management's 13F filing for Q2 2021, filed 11 Aug 2021.